Related Experiment Videos
Newly developed myocardial imaging by using single photon emission computed tomography (SPECT)
T Nishimura1, T Uehara, K Hayashida
1Department of Radiology, National Cardiovascular Center, Osaka, Japan.
Japanese Circulation Journal
|March 1, 1990
Summary
New single photon emission computed tomography (SPECT) imaging agents offer precise evaluation of myocardial infarction and ischemia. These techniques, including 111In-antimyosin, 123I-BMIPP, and 123I-MIBG, enhance characterization of damaged heart tissue.
Area of Science:
- Nuclear cardiology
- Cardiovascular imaging
- Radiopharmaceutical science
Background:
- Thallium myocardial imaging is established for assessing myocardial perfusion and viability in ischemic heart disease.
- Advancements in single photon emission computed tomography (SPECT) with gamma-emitting radiopharmaceuticals allow for more precise evaluation of myocardial infarction and ischemia.
Purpose of the Study:
- To evaluate novel myocardial imaging techniques through animal experiments and clinical applications.
- To assess the utility of specific radiopharmaceuticals for characterizing myocardial tissue.
Main Methods:
- Utilized SPECT imaging with novel agents: 111In-antimyosin for myocardial necrosis, 123I-beta-methyl-iodophenyl pentadecanoic acid (BMIPP) for fatty acid metabolism, and 123I-metaiodobenzyl guanidine (MIBG) for sympathetic neural activity.
- Employed dual-energy SPECT in conjunction with thallium imaging.
Main Results:
- Demonstrated the capability of new SPECT agents to assess myocardial necrosis, metabolic function, and neural activity.
- Dual-energy SPECT provided precise characterization of myocardial tissue in infarcted and ischemic regions when combined with thallium.
Conclusions:
- New SPECT imaging agents and dual-energy SPECT significantly improve the characterization of myocardial tissue in ischemic heart disease.
- These advanced techniques offer enhanced diagnostic precision for myocardial infarction and ischemia evaluation.